Federation des caisses Desjardins du Quebec’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$61.8K	Hold	1,415	–	–	﹤0.01%	1803
2025 Q4	$64.3K	Hold	1,415	–	–	﹤0.01%	1757
2025 Q3	$54.8K	Sell	1,415 -1	-0.1%	-$36	﹤0.01%	1786
2025 Q2	$47.7K	Hold	1,416	–	–	﹤0.01%	1570
2025 Q1	$45K	Buy	1,416 +1,062	+300%	+$40.3K	﹤0.01%	1502
2024 Q4	$13.7K	Hold	354	–	–	﹤0.01%	1771
2024 Q3	$15.9K	Hold	354	–	–	﹤0.01%	1732
2024 Q2	$14.8K	Hold	354	–	–	﹤0.01%	1698
2024 Q1	$16.1K	Hold	354	–	–	﹤0.01%	1695
2023 Q4	$16.4K	Hold	354	–	–	﹤0.01%	1634
2023 Q3	$14.4K	Hold	354	–	–	﹤0.01%	1660
2023 Q2	$17.1K	Sell	354 -25	-7%	-$1.25K	﹤0.01%	1619
2023 Q1	$18.7K	Hold	379	–	–	﹤0.01%	1588
2022 Q4	$19.2K	Hold	379	–	–	﹤0.01%	1691
2022 Q3	$19K	Hold	379	–	–	﹤0.01%	1749
2022 Q2	$18.5K	Buy	379 +87	+30%	+$4.41K	﹤0.01%	1783
2022 Q1	$17.5K	Buy	292 +4	+1%	+$252	﹤0.01%	1867
2021 Q4	$22.8K	Buy	288 +25	+10%	+$2.1K	﹤0.01%	1794
2021 Q3	$23.2K	Hold	263	–	–	﹤0.01%	1808
2021 Q2	$26.1K	Buy	263 +182	+225%	+$16.1K	﹤0.01%	1787
2021 Q1	$7.31K	Buy	+81	New	+$8K	﹤0.01%	2080

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's GNOM Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q1 2026 at 1,415 shares worth $61.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1803.

Federation des caisses Desjardins du Quebec first reported a position in GNOM in Q1 2021 and has held it in 21 quarters since. The position peaked at $64.3K in Q4 2025. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

Federation des caisses Desjardins du Quebec held 1,415 shares of Global X Genomics & Biotechnology ETF worth $61.8K as of Q1 2026.
Federation des caisses Desjardins du Quebec left its Global X Genomics & Biotechnology ETF share count unchanged in Q1 2026.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #1803 holding.
Federation des caisses Desjardins du Quebec first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and has held it in 21 quarters since.
Federation des caisses Desjardins du Quebec's Global X Genomics & Biotechnology ETF position peaked at $64.3K in Q4 2025.
40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.